MALT lymphoma secondary prevention: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{MALT lymphoma}}
{{MALT lymphoma}}
{{CMG}}{{AE}}{{SR}}
{{CMG}}{{AE}}{{SR}}, {{AY}}


==Overview==
==Overview==

Latest revision as of 19:08, 18 December 2017

MALT lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating MALT Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

CT

MRI

Endoscopic Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

MALT lymphoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of MALT lymphoma secondary prevention

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMALT lymphoma secondary prevention

CDC on MALT lymphoma secondary prevention

MALT lymphoma secondary prevention in the news

on MALT lymphoma secondary prevention

Directions to Hospitals Treating MALT lymphoma

Risk calculators and risk factors for MALT lymphoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ahmed Younes M.B.B.CH [3]

Overview

Secondary prevention strategies following MALT lymphoma include urease breath test, performed 4-6 weeks after completion of the course of antibiotic therapy, and endoscopy with concurrent biopsy, performed 3-6 months after the treatment is finished.[1]

Secondary Prevention

Secondary prevention strategies following MALT lymphoma include:[1]

  • 4-6 weeks after completion of the course of antibiotic therapy for eradication of H.pyroli, urease breath test is performed to check for H. pylori.
  • 3–6 months after the treatment has finished, endoscopy is performed. Biopsy is also performed simultaneously to confirm the eradication of H. pyroli infection and to assess whether the lymphoma is decreasing. The endoscopy is then performed every 4-6 months, eventually dropping to once a year.

References

  1. 1.0 1.1 Non-gastric lymphomas – causes, symptoms and treatments. Lymphoma association 2016. https://www.lymphomas.org.uk/sites/default/files/pdfs/Non-Gastric-malt-lymphoma.pdf. Accessed on January 28, 2016

Template:WH Template:WS